Baird analyst Vikram Kesavabhotla initiated coverage of Hinge Health (HNGE) with a Neutral rating and $56 price target
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HNGE:
- Hinge Health falls -8.5%
- Hinge Health’s Strategic Initiatives and Growth Potential Drive Buy Rating
- Hinge Health Announces Early Share Lock-Up Release
- Hinge Health’s Strategic Growth and Market Positioning: A Buy Recommendation by Ryan MacDonald
- Hinge Health’s Strong Growth and Margin Improvements Drive Buy Rating and Increased Price Objective